Araris Biotech
ararisbiotech.com
Actively hiring
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
2
Redalpine, Vi Partners
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Redalpine 
Vi Partners Similar startupsby what they do, their industry and backers
First-in-class ADCs tailored to attack advanced cancer.. Ona Therapeutics is pioneering the development of first-in-class antibody drug…
Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need…
Angiex is developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) to address the hallmarks of cancer lethality.
Novel ADC Payloads for Cancer Hexagon Bio is developing novel payload mechanisms for antibody-drug conjugates (ADCs) to overcome resistance…
THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse…
Ring Therapeutics is a biotechnology company creating novel vector conjugate medicines that carry more and reach further, expanding…
Overview
Building tomorrow's antibody-drug conjugates (ADCs). Araris Biotech AG, a spin-off company from the Paul Scherrer Institute (PSI) and ETH Zurich, is pioneering the development of a novel, proprietary antibody-drug conjugate (ADC)-linker technology.
News
Araris Biotech AG to Present Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2023
ZURICH, Switzerland, March 14, 2023 (GLOBE NEWSWIRE) -- Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker...
Read more
Report
Araris Listed among Top 15 Swiss Biotech Startups Making a Difference in Europe by Labbiotech.Eu
Really happy about being listed among so many great companies in Switzerland in Labbiotech.eu.
Read more
Report
Microbial transglutaminase (MTG) enables efficient and site-specific conjugation to native ... - Blog - Zedira GmbH
Zedira offers a huge portfolio of reliable specialist transglutaminase related products meant to catalyze research and development, both in academia and ...
Read more
Report